Key Market Indicators
Estonia's vaccination coverage for children aged one is projected to remain stable at 91% by 2028, according to recent data. This figure matches the current vaccination rate for this age group in 2023. The stability in vaccination coverage follows a slight year-on-year decline of 0.2 points since 1998. On the export front, Estonia's vaccine exports are forecasted to reach approximately $109,000 by 2028, up from $91,000 in 2023. This represents an annual growth rate of nearly 3%. Over the past two decades, the country's vaccine supply has grown at an annual rate of 2.7%. As of 2023, Estonia ranked 50th globally in vaccine exports, with Peru surpassing it at the same figure. Leading the vaccine export rankings were Belgium, the United Kingdom, and France, occupying the second, third, and fourth positions, respectively. Conversely, Estonia's vaccine imports are expected to decline significantly. By 2028, imports are projected to fall to around $815,000 from nearly $1.87 million in 2023, marking a yearly decrease of 13.3%. Since 2000, the country's demand for vaccine imports has decreased by 7.2% annually.
